Skip to content

Prospective Registry of EoSinophilic esOphagitis

Prospective Registry of EoSinophilic esOphagitis (PRESO)

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06443346
Acronym
PRESO
Enrollment
1000
Registered
2024-06-05
Start date
2024-06-01
Completion date
2044-12-31
Last updated
2025-07-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Eosinophilic Esophagitis

Brief summary

This is a prospective registry of all the Eosinophilic Esophagitis (EoE) patients referred to the third level referral centre of San Raffaele Scientific Institute

Detailed description

Primary objective of the study is to create a registry of all EoE patients with \> 18 years of age referring to the Motility and EoE Unit of San Raffaele Hospital, in order to register clinical, endoscopic and histologic data on the disease, to further design and propose future prospective or retrospective studies to increase disease knowledge and foster collaborations with other centers nationally and internationally

Interventions

OTHEREosinophilic Esophagitis

Eosinophilic Esophagitis patients with a proper diagnosis

Sponsors

IRCCS San Raffaele
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

1. Participant is willing and able to give informed consent for participation in the study. 2. The medical product is the standard of care for the patient or the participant is taking the medicinal product according to clinical practice 3. Being diagnosed with EoE as per guidelines of the disease

Exclusion criteria

1. No clear diagnosis of EoE 2. Not willing to provide informed consent to the inclusion in the registry

Design outcomes

Primary

MeasureTime frame
The prospective collection of histologic, endoscopic and clinical data on EoE patients10 years

Countries

Italy

Contacts

Primary ContactAlberto Barchi, MD
barchi.alberto@hsr.it3348630784

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026